Aclarion, Inc.

ACON

Explore Our Financial Data > Companies > Aclarion, Inc.
{{popupValue}}
{{popupSubtitle}}
Documentation
Excel
API
Download

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
ACON
CIK0001635077
SIC8071
SectorServices
Industry CategoryHealthcare
Industry GroupServices – Health

Contact

Address8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
Website aclarion.com
Phone833 275 2266
CEOBrent Ness
Employees7

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$54,601.00
Pre-Tax Income$-6.63 million
Net Income$-6.63 million
Net Income to Common$-6.70 million
EPS$-30.53
View All
Balance Sheet
Cash$14.75 million
Assets$16.48 million
Liabilities$699,032.00
Common Equity$15.78 million
Liabilities & Equity$16.48 million
View All
Cash Flow Statement
Net Income$-6.63 million
Cash From Operating Activities$-5.54 million
Cash From Investing Activities$-336,568.00
Cash From Financing Activities$18.50 million
Change in Cash$12.62 million
View All
Calculations
NOPAT$-4.01 million
EBITDA$-6.28 million
Price to EarningsN/A
Price to Book$0.26
ROE-72.53%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

Meeting adjourned to Monday, July 21, 2025 at 9:30 a.m. Mountain Time BROOMFIELD, Colo., July 07, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligence and a proprietary biomarker to optimize clinical treatments for low back and neck pain, today announced that its Annual Meeting of Stockholders (the “Annual Meeting”) scheduled for July 7, 2025 has

Article Link

First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

The first CLARITY patient was enrolled at the Texas Back Institute, a world leader in advancing spine technology, science, and education, as well as patient careCLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI)Company reaffirms internal interim results of CLARITY expec

Article Link

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

Dr. Kris Radcliff to Highlight MR Spectroscopy and Augmented Intelligence (AI)-Based Platform at State of Spine Surgery Think TankBROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the upcoming State of Spine

Article Link

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgeryCLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., June 10, 202

Article Link

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

USC Spine Center, part of Keck Medicine of USC, specializes in treating complex spine conditions with the latest cutting-edge technologiesCLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., May 20, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” o

Article Link